Promoter holding
64.27%
TL
Trigenesis Lifesciences Private Limited - Due diligence report
A 360° intelligence report on Trigenesis Lifesciences: trust score, financial health, credit view, compliance, directors, growth and distres…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Trigenesis Lifesciences — 360° Intelligence Report
Generated from MCA filings & public records82/100
Trust Score
Low Risk
Trigenesis Lifesciences is assessed as Low Risk with a Trust Score of 82/100. Trigenesis Lifesciences is an active private limited indian non-government company incorporated in 2004, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 27 Jul 2026 from the latest processed filings. Trigenesis Lifesciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
45/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Elevated gearing (D/E 38%).
- Working-capital cover adequate.
Charges position: 0 open (-) · 4 satisfied (4.85 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 1 | 48.0 cr |
| Others | 1 | 48.0 cr |
| Bank Of India | 1 | 48.0 cr |
| Bank Of Idia | 1 | 48.0 cr |
Compliance Score: 93/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- 1 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VIJAY NAHAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHAWARLAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2020)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
2
Group entities
4
Capital events
1 allotment(s) · 4 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Eugene Biosciences Private Limited | Subsidiary Company | 74.00% |
| Trigenesis Biosciences Private Limited | Subsidiary Company | 74.00% |
| Verogen Healthcare Private Limited | Associate Company | 74.00% |
| Avinya Lifesciences Private Limited | Associate Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 90
Growth signals & trust indicators
Operating for 22+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment55/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view52/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
14 Feb 2022
Charge satisfied
Others
18 Jun 2021
Charge created
Others - 1.00 cr
31 Dec 2020
Director ceased
BHAWARLAL
Director ceased
RAJINDER MEHTA
16 Sep 2020
Director ceased
KAPIL KUMAR BHAWARLAL JAIN
16 Dec 2019
Director appointed
BHAWARLAL (Director)
30 Sep 2019
Director ceased
VIJAY NAHAR
15 Jul 2019
Director appointed
VIJAY NAHAR (Director)
Director ceased
RAHUL JAIN
Director ceased
VINOD NAHAR
31 Mar 2018
Share transfer (FY 2018)
571400.00000000 shares to GOPAL SARDA
21 Mar 2018
Charge satisfied
Hdfc Bank Limited
31 Mar 2017
Share transfer (FY 2017)
10.00000000 shares to Bhawarlal Rahul
10
Key Observations
Auto-generated from the data aboveRevenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 4 registered charge(s) stand satisfied - past borrowings repaid.
Operates a group structure with 2 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Hvd Distributors Private Limited | U93000MH2010PTC202425 | Mumbai, Maharashtra, India |
| Gulbarga Suvarna Bhandar Private Limited | U36911KA2005PTC037209 | Gulbarga, Karnataka, India |
| Wellsun Farmer Fertilizer Private Limited | U24120GJ2013PTC076257 | Anand, Gujarat, India |
| Zanon Lifesciences Private Limited | U24232CH2011PTC033374 | Chandigarh, Chandigarh, India |
| Ajaymeru Float Glass Private Limited | U26100RJ2020PTC069667 | Jaipur, Rajasthan, India |
| Kje India Private Limited | U29309MH2019PTC322902 | Aurangabad, Maharashtra, India |
| Damy Royal Style Private Limited | U92490HR2012PTC046671 | Faridabad, Haryana, India |
| Advait Tea & Agro Product Private Limited | U01403WB2012PTC184007 | Siliguri, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Trigenesis Lifesciences before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Trigenesis Lifesciences: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Trigenesis Lifesciences - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Trigenesis Lifesciences pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Trigenesis Lifesciences - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Trigenesis Lifesciences an active company?
Trigenesis Lifesciences has MCA status “Active” with a compliance score of 93/100 (Low Risk).
Is Trigenesis Lifesciences financially healthy?
Trigenesis Lifesciences has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Trigenesis Lifesciences?
Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Trigenesis Lifesciences?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Trigenesis Lifesciences have loans or charges against its assets?
No open charges - all 4 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Trigenesis Lifesciences up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).
Is it risky to lend to Trigenesis Lifesciences?
Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
